Anti-YIPF5 monoclonal antibody

Pre-made anti-YIPF5 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to YIPF5/YIPF5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2289-Ab-1/ GM-Tg-hg-IP2289-Ab-2Anti-Human YIPF5 monoclonal antibodyHuman
GM-Tg-rg-IP2289-Ab-1/ GM-Tg-rg-IP2289-Ab-2Anti-Rat YIPF5 monoclonal antibodyRat
GM-Tg-mg-IP2289-Ab-1/ GM-Tg-mg-IP2289-Ab-2Anti-Mouse YIPF5 monoclonal antibodyMouse
GM-Tg-cynog-IP2289-Ab-1/ GM-Tg-cynog-IP2289-Ab-2Anti-Cynomolgus/ Rhesus macaque YIPF5 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2289-Ab-1/ GM-Tg-felg-IP2289-Ab-2Anti-Feline YIPF5 monoclonal antibodyFeline
GM-Tg-cang-IP2289-Ab-1/ GM-Tg-cang-IP2289-Ab-2Anti-Canine YIPF5 monoclonal antibodyCanine
GM-Tg-bovg-IP2289-Ab-1/ GM-Tg-bovg-IP2289-Ab-2Anti-Bovine YIPF5 monoclonal antibodyBovine
GM-Tg-equg-IP2289-Ab-1/ GM-Tg-equg-IP2289-Ab-2Anti-Equine YIPF5 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2289-Ab-1/ GM-Tg-hg-IP2289-Ab-2; GM-Tg-rg-IP2289-Ab-1/ GM-Tg-rg-IP2289-Ab-2;
GM-Tg-mg-IP2289-Ab-1/ GM-Tg-mg-IP2289-Ab-2; GM-Tg-cynog-IP2289-Ab-1/ GM-Tg-cynog-IP2289-Ab-2;
GM-Tg-felg-IP2289-Ab-1/ GM-Tg-felg-IP2289-Ab-2; GM-Tg-cang-IP2289-Ab-1/ GM-Tg-cang-IP2289-Ab-2;
GM-Tg-bovg-IP2289-Ab-1/ GM-Tg-bovg-IP2289-Ab-2; GM-Tg-equg-IP2289-Ab-1/ GM-Tg-equg-IP2289-Ab-2
Products NameAnti-YIPF5 monoclonal antibody
Formatmab
Target NameYIPF5
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-YIPF5 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2289-Ag-1Recombinant multi-species YIPF5/ FinGER5/ SB140 protein


    Target information

    Target IDGM-IP2289
    Target NameYIPF5
    Gene ID81555,67180,361315,706656,478048,101081359,521829,100061189
    Gene Symbol and Synonyms2610311I19Rik,Ac2-256,FinGER5,MEDS2,SB140,SMAP-5,SMAP5,YIP1A,YIPF5
    Uniprot AccessionQ969M3,Q5XID0,Q5E9E8
    Uniprot Entry NameYIPF5_HUMAN,YIPF5_RAT,YIPF5_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000145817
    Target ClassificationN/A

    The target: YIPF5, gene name: YIPF5, also named as FinGER5, SB140, SMAP-5, SMAP5, YIP1A. Predicted to be involved in endoplasmic reticulum to Golgi vesicle-mediated transport; regulation of ER to Golgi vesicle-mediated transport; and vesicle fusion with Golgi apparatus. Located in Golgi apparatus; endoplasmic reticulum; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.